""Expert medical care is right in your neighborhood with the physicians of Atlantic Medical Group. We offer high-quality, compassionate care and are directly connected with renowned specialists and the award-winning hospitals of Atlantic Health System. Schedule an appointment with us today – most major medical insurance plans accepted.""

During the past decade, Institute for Rheumatic and Autoimmune Diseases conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Institute for Rheumatic and Autoimmune Diseases" are "Lupus Nephritis" (1 trials), "Still's Disease, Adult-Onset" (1 trials) and "Still's Disease, Juvenile-Onset" (1 trials). Many other conditions were trialed in "Institute for Rheumatic and Autoimmune Diseases" in a lesser frequency.

Most popular intervention types in "Institute for Rheumatic and Autoimmune Diseases" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BMS-986165" (1 trials), "Mycophenolate Mofetil" (1 trials) and "anakinra" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute for Rheumatic and Autoimmune Diseases" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institute for Rheumatic and Autoimmune Diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institute for Rheumatic and Autoimmune Diseases, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Institute for Rheumatic and Autoimmune Diseases, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".